BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30067557)

  • 1. c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.
    Chaudhary N; Shapiro N; Bhutada A; Rastogi S
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e338-e340. PubMed ID: 30067557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
    Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mastocytosis.
    Abid A; Malone MA; Curci K
    Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
    Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
    J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
    Angus J; Leach IH; Grant J; Ravenscroft JC
    Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero presentation of aggressive systemic mastocytosis in a neonate.
    Huang A; Fiadorchanka N; Brar K; Balderacchi JL; Glick SA
    Br J Dermatol; 2017 Nov; 177(5):1439-1441. PubMed ID: 28369700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: a case review.
    Ustun C; Savage NM; Gotlib J; Bhalla K; Manaloor E; George TI
    Am J Hematol; 2012 Feb; 87(2):191-3. PubMed ID: 22081475
    [No Abstract]   [Full Text] [Related]  

  • 10. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
    Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
    Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis of mast cell activation disease - looking through a glass darkly.
    Molderings GJ
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic characteristics of Chinese neonates with cutaneous mastocytosis: a case report and literature review.
    Li Y; Li X; Liu X; Kang L; Liu X
    J Int Med Res; 2020 Sep; 48(9):300060520952621. PubMed ID: 32883129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
    Vergara-de-la-Campa L; Torrado I; Recuero-Pradillo M; Torrelo A; Gironella M; Pardal E; Godoy AC; Matito A; Pérez-Hortet C; Mollejo M; Álvarez-Twöse I
    J Dermatol; 2021 May; 48(5):657-660. PubMed ID: 33684229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mastocytosis and related disorders.
    Chiu A; Orazi A
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of mast cell activation disorders.
    Petra AI; Panagiotidou S; Stewart JM; Conti P; Theoharides TC
    Expert Rev Clin Immunol; 2014 Jun; 10(6):729-39. PubMed ID: 24784142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.
    Lesnoni La Parola I; Cannistraci C; Izzi S; Pisani F; Amantea A; Rongioletti F
    Int J Dermatol; 2014 Oct; 53(10):1265-8. PubMed ID: 24738598
    [No Abstract]   [Full Text] [Related]  

  • 19. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.